Growth factor receptor inhibitor Keratinocyte growth factor Neurotrophic factor receptor Tyrosine kinase inhibitor GDNF family of ligands Fibroblast growth factor Growth factor receptor Ramucirumab Ephrin Duligotuzumab Mirvetuximab soravtansine Rilotumumab Icrucumab Becaplermin Onartuzumab Ertumaxomab Neuregulin Figitumumab Ciliary neurotrophic factor receptor Robatumumab FGF16 Cerebrolysin FGF15/19 FGF20 IGF-1 LR3 Ficlatuzumab Teprotumumab Emibetuzumab Imgatuzumab Insulin-like growth factor-binding protein Flanvotumab Dalotuzumab Pertuzumab/trastuzumab/hyaluronidase Mecasermin rinfabate Faricimab Hemopoietic…

c growth factor Platelet-derived growth factor FGF15 Fulranumab Futuximab Alacizumab pegol FGF22 Palifermin Matuzumab Ancestim Neurotrophin Trafermin Angiopoietin Nimotuzumab Amivantamab Necitumumab Adult neurogenesis Neurotrophic factors Trastuzumab/hyaluronidase Seribantumab Tovetumab FGF11 Anti-VEGF Patritumab Pertuzumab Des(1-3)IGF-1 Dusigitumab Cenegermin BNN-20 Semaxanib Bevacizumab Trk receptor Evinacumab R13 (drug) Norwogonin Cetuximab Eu

tropoflavin Cixutumumab Persephin Ganitumab GFRα Neurturin Zalutumumab Fasinumab Nesvacumab LM22A-4 Brolucizumab HIOC Motesanib ANA-12 Dihexa Vascular endothelial growth factor 7,8,3'-Trihydroxyflavone Glia maturation factor Grandinin Mecasermin Cediranib Fruquintinib Trofinetide IGFBP7 RTK class III Olaratumab R7 (drug) Panitumumab Ranibizumab Pralsetinib Olmutinib Tyrosine kinase Receptor activity-modifying protein Linsitinib Renalase Tepotinib Neratinib Trastuzumab emtansine Epigen Selpercatinib Nilotinib Asciminib Brigatinib Binimetinib Rociletinib Trastuzumab Trametinib Avapritinib Neuregulin 4 Tavilermide Ephrin receptor IGFBP6 Growth factor BNN-27 Deoxygedunin Tivozanib Pemigatinib